Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth.

MLA

Chan, Loucia Kit Ying, et al. “Short-Form Thymic Stromal Lymphopoietin (SfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth.” Cancers, vol. 13, no. 5, Mar. 2021, p. 980. EBSCOhost, https://doi.org/10.3390/cancers13050980.

APA

Chan, L. K. Y., Lau, T. S., Chung, K. Y., Tam, C., Cheung, T. H., Yim, S. F., Lee, J. H. S., Leung, R. W. T., Qin, J., Or, Y. Y. Y., Lo, K. W., Kwong, J., & Morandi, A. (2021). Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers, 13(5), 980. https://doi.org/10.3390/cancers13050980

Chicago

Chan, Loucia Kit Ying, Tat San Lau, Kit Ying Chung, Chit Tam, Tak Hong Cheung, So Fan Yim, Jacqueline Ho Sze Lee, et al. 2021. “Short-Form Thymic Stromal Lymphopoietin (SfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth.” Cancers 13 (5): 980. doi:10.3390/cancers13050980.